Monopar Therapeutics Stock (NASDAQ: MNPR) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 5.331M |
Day Range | - - - |
52 Wk Range | 0.274 - 1.750 |
Market Cap | $11.620M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | 3.32% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Monopar Therapeutics (NASDAQ: MNPR) through any online brokerage.
Other companies in Monopar Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN), Coeptis Therapeutics (NASDAQ:COEP) and Nanoviricides (AMEX:NNVC).
The latest price target for Monopar Therapeutics (NASDAQ: MNPR) was reported by JonesTrading on Thursday, April 11, 2024. The analyst firm set a price target for 2.00 expecting MNPR to rise to within 12 months (a possible 200.44% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Monopar Therapeutics (NASDAQ: MNPR) is $0.6657 last updated April 23, 2024 at 6:16 PM EDT.
There are no upcoming dividends for Monopar Therapeutics.
Monopar Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Monopar Therapeutics.
Monopar Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.